Connection

KALPALATHA GUNTUPALLI to Shock, Septic

This is a "connection" page, showing publications KALPALATHA GUNTUPALLI has written about Shock, Septic.
Connection Strength

0.331
  1. Whole-body CO2 production as an index of the metabolic response to sepsis. Shock. 2009 Jul; 32(1):23-8.
    View in: PubMed
    Score: 0.068
  2. Arginine, citrulline and nitric oxide metabolism in sepsis. Clin Sci (Lond). 2009 Jun 02; 117(1):23-30.
    View in: PubMed
    Score: 0.068
  3. In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis. Am J Clin Nutr. 2006 Jul; 84(1):197-203.
    View in: PubMed
    Score: 0.055
  4. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med. 2004 Jan; 32(1):13-20.
    View in: PubMed
    Score: 0.047
  5. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med. 1999 May; 27(5):913-22.
    View in: PubMed
    Score: 0.034
  6. Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Clin Pharmacol Ther. 1999 Jan; 65(1):1-9.
    View in: PubMed
    Score: 0.033
  7. Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial. Crit Care Med. 2015 Sep; 43(9):1832-8.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.